Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Patent Law

: Patent Docs

Biotech/Pharma Business Briefs

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

ADVERTISEMENTS

By Jason Derry --Merck to Buy Biologics Division from Insmed Insmed Inc. and Merck have announced a deal in which Merck will purchase Insmed's research and production division and facility for developing follow-on biologics for $130 million (see Insmed press release). Merck will receive Insmed's follow-on biologics platform, and its development and production facility located in Boulder, CO. Insmed's pipeline of follow-on biologics includes biosimilar versions of Amgen's Neupogen and Neulasta. Merck is obtaining development and commercial rights for these follow-on biologic candidates. GSK Licenses HIV Drug Candidate GlaxoSmithKline and Idenix Pharmaceuticals, Inc. have announced that GSK has licensed worldwide...

Full post as published by Patent Docs on February 14, 2009 (boomark / email).

Lawsuits and Settlements

Class Action Filed Over Incontinence Briefs
Arizona Health Care Faces Federal Class Action over Incontinence Briefs

Medical Records
To Stay out of Pharma's Hands

Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

Express Scripts Inc.
Over $9.5 million payout in deceptive business practices lawsuit.

FedEx
Ground Business Model Wins Class Action in Washington

Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements

Related Searches